Companies Plan Presentations at H.C. Wainwright Conference

Assembly Biosciences, Nanobiotix, Artelo Biosciences and Fortress Biotech announced plans to present at the H.C. Wainwright 28th Annual Global Investment Conference. Nanobiotix said co-founder and Chairman Laurent Lévy and Chief Financial and Business Officer Bart Van Rhijn will participate in a fireside chat in New York on September 15, 2026. The other companies will provide corporate or business updates, with some also scheduling one-on-one meetings with investors. Their presentations will be available through conference or company webcast platforms, underscoring the event’s role as an investor-outreach opportunity for biotechnology and pharmaceutical companies.